Cancer drugs' sexual toxicity warrants a "call to action" among oncologists to address the problem. ( Lancet Oncology) U.S.

What prominent human rights and good governance advocate Mugambi Kiai thought was a routine medical check led to the shock discovery of a life-changing disease that has thrown him into unchartered ...

Faron is planning for a Phase III trial, pending U.S Food and Drug Administration (FDA) End of Phase II meeting Feedback TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON ...

TURKU, FI / ACCESS Newswire / April 15, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Inside Information: BEXMAB Phase II trial met its primary endpoint in treatment-resistant High Risk MDS ...

All relevant comments and Faron Pharmaceuticals Oy share chat regarding the FARN LON share news are listed here in the FARN forum. View and contribute to the FARN share chat. Discuss Faron ...

Faron is planning for a Phase III trial, pending U.S Food and Drug Administration (FDA) End of Phase II meeting Feedback TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a ...

Faron Pharmaceuticals PLC on Tuesday - Turku, Finland-based developer of cancer immunotherapies - Presents full analysis of positive phase 2 interim data from Bexmab trial at the annual meeting of the ...